Desquamative interstitial pneumonia induced by metal exposure. A case report and literature review.


Journal

Sarcoidosis, vasculitis, and diffuse lung diseases : official journal of WASOG
ISSN: 2532-179X
Titre abrégé: Sarcoidosis Vasc Diffuse Lung Dis
Pays: Italy
ID NLM: 9610928

Informations de publication

Date de publication:
2020
Historique:
received: 16 12 2019
accepted: 07 02 2020
entrez: 23 10 2020
pubmed: 24 10 2020
medline: 4 11 2020
Statut: ppublish

Résumé

Forms of interstitial pneumonia secondary to exposure to an air-contaminant are varied and so far, insufficiently described. We report here a case of a 57-year-old patient managed in our department for the exploration of MRC grade 2 dyspnoea and interstitial pneumonia. He mentioned multiple occupational and domestic exposures such as hens' excrements, asbestos and metal particles; he also had a previous history of smoking. High-resolution computed tomography showed ground glass opacities predominating in posterior territories and surrounding cystic lesions or emphysematous destruction. The entire etiological assessment revealed only macrophagic alveolitis with giant multinucleated cells on the bronchoalveolar lavage. A surgical lung biopsy allowed us to refine the diagnosis with evidence of desquamative interstitial pneumonia and pulmonary granulomatosis. Finally, the analysis of the mineral particles in the biopsy revealed abnormally high rates of Zirconium and Aluminium. We were therefore able to conclude to a desquamative interstitial pneumonia associated with pulmonary granulomatosis linked to metal exposure (Aluminium and Zirconium). The clinical, functional and radiological evolution was favorable after a systemic corticosteroid treatment with progressive decay over one year. This presentation reports the first case to our knowledge of desquamative interstitial pneumonitis related to exposure to Zirconium and the third one in the context of Aluminium exposure. The detailed analysis of the mineral particles present on the surgical lung biopsy allows for the identification of the relevant particle to refine the etiological diagnosis, to guide the therapeutic management and to give access to recognition as an occupational disease.

Sections du résumé

BACKGROUND BACKGROUND
Forms of interstitial pneumonia secondary to exposure to an air-contaminant are varied and so far, insufficiently described.
OBJECTIVES/METHODS OBJECTIVE
We report here a case of a 57-year-old patient managed in our department for the exploration of MRC grade 2 dyspnoea and interstitial pneumonia. He mentioned multiple occupational and domestic exposures such as hens' excrements, asbestos and metal particles; he also had a previous history of smoking.
RESULTS RESULTS
High-resolution computed tomography showed ground glass opacities predominating in posterior territories and surrounding cystic lesions or emphysematous destruction. The entire etiological assessment revealed only macrophagic alveolitis with giant multinucleated cells on the bronchoalveolar lavage. A surgical lung biopsy allowed us to refine the diagnosis with evidence of desquamative interstitial pneumonia and pulmonary granulomatosis. Finally, the analysis of the mineral particles in the biopsy revealed abnormally high rates of Zirconium and Aluminium. We were therefore able to conclude to a desquamative interstitial pneumonia associated with pulmonary granulomatosis linked to metal exposure (Aluminium and Zirconium). The clinical, functional and radiological evolution was favorable after a systemic corticosteroid treatment with progressive decay over one year.
CONCLUSION CONCLUSIONS
This presentation reports the first case to our knowledge of desquamative interstitial pneumonitis related to exposure to Zirconium and the third one in the context of Aluminium exposure. The detailed analysis of the mineral particles present on the surgical lung biopsy allows for the identification of the relevant particle to refine the etiological diagnosis, to guide the therapeutic management and to give access to recognition as an occupational disease.

Identifiants

pubmed: 33093772
doi: 10.36141/svdld.v37i1.9103
pii: SVDLD-37-79
pmc: PMC7569535
doi:

Substances chimiques

Adrenal Cortex Hormones 0
Zirconium C6V6S92N3C
Aluminum CPD4NFA903

Types de publication

Case Reports Journal Article Review

Langues

eng

Pagination

79-84

Informations de copyright

Copyright: © 2020 SARCOIDOSIS VASCULITIS AND DIFFUSE LUNG DISEASES.

Références

Respir Med Case Rep. 2017 Feb 06;20:150-153
pubmed: 28239542
Sarcoidosis Vasc Diffuse Lung Dis. 2016 Aug 01;33(2):166-70
pubmed: 27537720
Rev Inst Hyg Mines (Hasselt). 1974;29(3):125-9
pubmed: 4464563
Hum Pathol. 1982 Aug;13(8):694-9
pubmed: 7106732
Am J Respir Crit Care Med. 2018 Sep 1;198(5):e44-e68
pubmed: 30168753
Eur Respir J. 2016 Nov;48(5):1453-1461
pubmed: 27660509
Environ Health Perspect. 2000 Aug;108 Suppl 4:685-96
pubmed: 10931787
Am J Respir Crit Care Med. 2019 May 15;199(10):1249-1256
pubmed: 30864813
Asian Cardiovasc Thorac Ann. 2015 Feb;23(2):191-7
pubmed: 25193985
Thorax. 1983 Feb;38(2):119-28
pubmed: 6857569
J Bras Pneumol. 2016 Nov-Dec;42(6):447-452
pubmed: 28117477
Am J Med. 1965 Sep;39:369-404
pubmed: 14338290
Eur Respir Rev. 2013 Jun 1;22(128):117-23
pubmed: 23728865
Food Chem Toxicol. 1984 Jan;22(1):39-43
pubmed: 6537935
Eur Respir J. 1998 Sep;12(3):750
pubmed: 9762810
Zhonghua Jie He He Hu Xi Za Zhi. 2017 Oct 12;40(10):760-765
pubmed: 29050131
Zhonghua Jie He He Hu Xi Za Zhi. 2006 May;29(5):313-6
pubmed: 16759488
Am J Respir Crit Care Med. 2013 Sep 15;188(6):733-48
pubmed: 24032382
Nouv Presse Med. 1975 May 3;4(18):1353-55
pubmed: 1153297
Sarcoidosis Vasc Diffuse Lung Dis. 2014 Oct 20;31(3):262-4
pubmed: 25363230
Am J Ind Med. 1994 Nov;26(5):585-95
pubmed: 7832207

Auteurs

Timothée Blin (T)

Service de Pneumologie et d'explorations fonctionnelles respiratoires, CHU Bretonneau, Tours, France.
Centre d'Etude des Pathologies Respiratoires, UMR 1100/EA6305, Tours, France.

Anne De Muret (A)

Service d'anatomopathologie, CHU Bretonneau, Tours, France.

Marion Teulier (M)

Service de Pneumologie et d'explorations fonctionnelles respiratoires, CHU Bretonneau, Tours, France.

Marion Ferreira (M)

Service de Pneumologie et d'explorations fonctionnelles respiratoires, CHU Bretonneau, Tours, France.
Centre d'Etude des Pathologies Respiratoires, UMR 1100/EA6305, Tours, France.

Michel Vincent (M)

Minapath développement Insavalor cei2, Villeurbanne, France.

Mickaël Catinon (M)

Laboratory of mineral pathologies at the Saint Joseph Saint Luc Hospital Centre, Lyon, France.

Antoine Legras (A)

Thoracic and cardiovascular department, Tours University Hospital, CHRU Tours, France.

Patrice Diot (P)

Service de Pneumologie et d'explorations fonctionnelles respiratoires, CHU Bretonneau, Tours, France.
Centre d'Etude des Pathologies Respiratoires, UMR 1100/EA6305, Tours, France.

Sylvain Marchand-Adam (S)

Service de Pneumologie et d'explorations fonctionnelles respiratoires, CHU Bretonneau, Tours, France.
Centre d'Etude des Pathologies Respiratoires, UMR 1100/EA6305, Tours, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH